No Data
No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Upgrade: Analysts Just Made A Meaningful Increase To Their Curis, Inc. (NASDAQ:CRIS) Forecasts
H.C. Wainwright Maintains Curis(CRIS.US) With Buy Rating, Maintains Target Price $16
Curis to Present at Upcoming Healthcare Conference in April
H.C. Wainwright Maintains Curis(CRIS.US) With Buy Rating, Cuts Target Price to $16
Curis's Promising Clinical Developments and Strategic Path to Accelerated Approval Boost Buy Rating